GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Biosign Technologies Inc (TSXV:BIO.H) » Definitions » Asset Turnover

Biosign Technologies (TSXV:BIO.H) Asset Turnover : 0.01 (As of Sep. 2015)


View and export this data going back to 2010. Start your Free Trial

What is Biosign Technologies Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Biosign Technologies's Revenue for the three months ended in Sep. 2015 was C$0.07 Mil. Biosign Technologies's Total Assets for the quarter that ended in Sep. 2015 was C$5.17 Mil. Therefore, Biosign Technologies's Asset Turnover for the quarter that ended in Sep. 2015 was 0.01.

Asset Turnover is linked to ROE % through Du Pont Formula. Biosign Technologies's annualized ROE % for the quarter that ended in Sep. 2015 was -601.24%. It is also linked to ROA % through Du Pont Formula. Biosign Technologies's annualized ROA % for the quarter that ended in Sep. 2015 was 517.15%.


Biosign Technologies Asset Turnover Historical Data

The historical data trend for Biosign Technologies's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosign Technologies Asset Turnover Chart

Biosign Technologies Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Asset Turnover
Get a 7-Day Free Trial 0.01 0.05 0.02 0.01 0.11

Biosign Technologies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.02 0.03 0.01

Competitive Comparison of Biosign Technologies's Asset Turnover

For the Health Information Services subindustry, Biosign Technologies's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosign Technologies's Asset Turnover Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Biosign Technologies's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Biosign Technologies's Asset Turnover falls into.



Biosign Technologies Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Biosign Technologies's Asset Turnover for the fiscal year that ended in Dec. 2014 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2014 )/( (Total Assets (A: Dec. 2013 )+Total Assets (A: Dec. 2014 ))/ count )
=0.667/( (4.116+7.556)/ 2 )
=0.667/5.836
=0.11

Biosign Technologies's Asset Turnover for the quarter that ended in Sep. 2015 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2015 )/( (Total Assets (Q: Jun. 2015 )+Total Assets (Q: Sep. 2015 ))/ count )
=0.073/( (6.281+4.065)/ 2 )
=0.073/5.173
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Biosign Technologies  (TSXV:BIO.H) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Biosign Technologies's annulized ROE % for the quarter that ended in Sep. 2015 is

ROE %**(Q: Sep. 2015 )
=Net Income/Total Stockholders Equity
=26.752/-4.4495
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(26.752 / 0.292)*(0.292 / 5.173)*(5.173/ -4.4495)
=Net Margin %*Asset Turnover*Equity Multiplier
=9161.64 %*0.0564*-1.1626
=ROA %*Equity Multiplier
=517.15 %*-1.1626
=-601.24 %

Note: The Net Income data used here is four times the quarterly (Sep. 2015) net income data. The Revenue data used here is four times the quarterly (Sep. 2015) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Biosign Technologies's annulized ROA % for the quarter that ended in Sep. 2015 is

ROA %(Q: Sep. 2015 )
=Net Income/Total Assets
=26.752/5.173
=(Net Income / Revenue)*(Revenue / Total Assets)
=(26.752 / 0.292)*(0.292 / 5.173)
=Net Margin %*Asset Turnover
=9161.64 %*0.0564
=517.15 %

Note: The Net Income data used here is four times the quarterly (Sep. 2015) net income data. The Revenue data used here is four times the quarterly (Sep. 2015) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Biosign Technologies Asset Turnover Related Terms

Thank you for viewing the detailed overview of Biosign Technologies's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosign Technologies (TSXV:BIO.H) Business Description

Traded in Other Exchanges
N/A
Address
13-3715 Laird Road, Mississauga, ON, CAN, L5L 0A3
Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale of hardware. The software is delivered through the cloud from the company's hosting facilities.

Biosign Technologies (TSXV:BIO.H) Headlines

No Headlines